Invention Grant
US07674291B2 Human skin equivalents expressing exogenous polypeptides 有权
表达外源多肽的人皮肤当量

Human skin equivalents expressing exogenous polypeptides
Abstract:
The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
Public/Granted literature
Information query
Patent Agency Ranking
0/0